₹362
▼ -7.31 -1.98%
As of 27 Jul 2026 · delayed
NSE Listed
Indraprastha Medical Corporation Ltd. (INDRAMEDCO)
20-day avg volume: 1.0L shares
- Stock trades at a high P/E of 81.
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹348 Cr | ₹350 Cr | ₹325 Cr | ₹334 Cr | ₹365 Cr | ₹381 Cr | ₹372 Cr | ₹365 Cr |
| EBITDA | ₹61 Cr | ₹59 Cr | ₹46 Cr | ₹57 Cr | ₹70 Cr | ₹68 Cr | ₹58 Cr | ₹57 Cr |
| Net Profit | ₹45 Cr | ₹42 Cr | ₹33 Cr | ₹41 Cr | ₹51 Cr | ₹49 Cr | ₹41 Cr | ₹42 Cr |
| EPS | — | — | — | — | — | — | — | — |
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹753 Cr | ₹789 Cr | ₹831 Cr | ₹614 Cr | ₹891 Cr | ₹1,109 Cr | ₹1,262 Cr | ₹1,379 Cr |
| EBITDA | ₹43 Cr | ₹51 Cr | ₹54 Cr | ₹8 Cr | ₹82 Cr | ₹121 Cr | ₹170 Cr | ₹223 Cr |
| Net Profit | ₹21 Cr | ₹28 Cr | ₹44 Cr | ₹2 Cr | ₹59 Cr | ₹86 Cr | ₹124 Cr | ₹161 Cr |
| EPS | 2.3 | 3.1 | 4.76 | 0.25 | 6.39 | 9.4 | 13.52 | 17.56 |
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹422 Cr | ₹449 Cr | ₹432 Cr | ₹462 Cr | ₹555 Cr | ₹723 Cr | ₹852 Cr | ₹991 Cr |
| Total Liabilities | ₹178 Cr | ₹181 Cr | ₹159 Cr | ₹136 Cr | ₹176 Cr | ₹245 Cr | ₹255 Cr | ₹251 Cr |
| Equity | ₹244 Cr | ₹268 Cr | ₹273 Cr | ₹325 Cr | ₹379 Cr | ₹478 Cr | ₹597 Cr | ₹740 Cr |
| Total Debt | — | — | — | — | — | — | — | ₹37 Cr |
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | ₹36 Cr | ₹114 Cr | ₹154 Cr | ₹247 Cr | ₹218 Cr | ₹167 Cr |
| Investing | ₹-19 Cr | ₹-74 Cr | ₹-108 Cr | ₹-158 Cr | ₹-111 Cr | ₹-178 Cr |
| Financing | ₹-3 Cr | ₹-3 Cr | ₹-26 Cr | ₹-32 Cr | ₹-46 Cr | ₹-46 Cr |
| Free Cash Flow | ₹36 Cr | ₹114 Cr | ₹154 Cr | ₹247 Cr | ₹218 Cr | ₹108 Cr |
Healthcare · Medical Care Facilities
Indraprastha Medical Corporation Limited provides hospital services in India. The company offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, urology, and plastic surgery, as well as pediatric urology and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency, gastroenterology, neuroscience, critical care, orthopedics, robotic surgery, and organ transplant, as well as laboratory services, interventional medicine, preventive medicine, and sleep medicine. Indraprastha Medical Corporation Limited was founded in 1983 and is based in New Delhi, India.
www.apollohospitals.com/delhi ↗As of 2026-06-30
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 51% | 51% | 51% | 51% | 51% | 51% | 51% | 51% | 51% | 51% | 51% | 51% |
| FIIs | 0.8% | 0.9% | 1.1% | 1.7% | 2.6% | 2.9% | 2.9% | 2.7% | 2.4% | 2.7% | 2.4% | 2.8% |
| DIIs | 6.7% | 6.4% | 4.9% | 3.2% | 3.2% | 3.2% | 3.6% | 3.6% | 3.5% | 0.8% | 0.9% | 0.6% |
| Public | 41.5% | 41.7% | 43% | 44.2% | 43.2% | 42.9% | 42.5% | 42.7% | 43.1% | 45.4% | 45.7% | 45.6% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 47,865 | 51,448 | 54,158 | 55,103 | 64,671 | 69,697 | 70,491 | 70,211 | 70,914 | 71,225 | 72,980 | 75,098 |
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
| Name | Category | Stake | Shares |
|---|---|---|---|
| President Of India | Shareholding of Promoter and Promoter Group | 26% | 2.38 Cr |
| Apollo Hospitals Enterprises Limited | Shareholding of Promoter and Promoter Group | 22% | 2.02 Cr |
| Vanaja Sundar Iyer | Public Shareholding | 2% | 18,05,333 |
| Emedlife Insurance Broking Services Limited | Public Shareholding | 1.7% | 15,57,411 |
| Wedgewood Holdings Limited | Shareholding of Promoter and Promoter Group | 1.6% | 14,75,000 |
| Citadel Research And Solutions Limited | Public Shareholding | 1.3% | 11,82,983 |
| Pcr Investment Limited | Shareholding of Promoter and Promoter Group | 0.4% | 3,87,423 |
| Pratap C Reddy | Shareholding of Promoter and Promoter Group | 0.3% | 2,37,187 |
| Preetha Reddy | Shareholding of Promoter and Promoter Group | 0.2% | 2,02,650 |
| Sucharitha P Reddy | Shareholding of Promoter and Promoter Group | 0.2% | 1,60,689 |
| Suneeta Reddy | Shareholding of Promoter and Promoter Group | 0.2% | 1,38,293 |
| Shobana Kamineni | Shareholding of Promoter and Promoter Group | 0.1% | 1,16,918 |
| Sangita Reddy | Shareholding of Promoter and Promoter Group | 0% | 9,900 |
| K S Baidwan | Shareholding of Promoter and Promoter Group | 0% | 1 |
| P V Jayakrishan | Shareholding of Promoter and Promoter Group | 0% | 1 |
| Ramesh Chander | Shareholding of Promoter and Promoter Group | 0% | 1 |
| Vineetarai | Shareholding of Promoter and Promoter Group | 0% | 1 |
| Name | Designation | Year |
|---|---|---|
| Prathap C Reddy | Vice Chairman | 2025 |
| Suneeta Reddy | Non-Exec & Non-Independent Dir | 2025 |
| Sangita Reddy | Non-Exec & Non-Independent Dir | 2025 |
| Mahesh Verma | Non Independent Non Executive Director / Nominee | 2025 |
| MADHUMITA GANGULI | Independent Non Exe. Director | 2025 |
| Salil Singhal | Independent Non Exe. Director | 2025 |
| Vineeta Rai | Independent Non Exe. Director | 2025 |
| Vinayak Chatterjee | Independent Non Exe. Director | 2025 |
| P Shivakumar | ED / MD / Promoter | 2025 |
| Sandip Somany | Independent Non Exe. Director | 2025 |
| Tejpreet S Chopra | Independent Non Exe. Director | 2025 |
| SUDHIR JALAN | Independent Non Exe. Director | 2025 |
| PRIYA RANJAN | AVP - Corporate Affairs & Legal / CS | 2025 |
| Segment | Revenue | Share |
|---|---|---|
| Healthcare | ₹0 Cr | — |
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 100 | 92 | 92 |
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-08-06 | Board Meetings | — |
| dividend | 2025-09-18 | ₹4.5 (45%) | Final |
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 8 | 149 | 157 |
| 2025 | 0 | 0 | 0 | 0 | 12 | 12 |
| 2025 | 0 | 0 | 0 | 0 | 17 | 17 |
1 disclosure(s)
📍 Sarita Vihar, Delhi-Mathura Road, New Delhi, New Delhi, 110076
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search